| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2786 |
| Trial ID | NCT05038696 |
| Disease | Acute Lymphoblastic Leukemia | Childhood B-Cell Acute Lymphoblastic Leukemia | Childhood Acute Lymphoblastic Leukemia | Encephalopathy Syndrome |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ALaCAR-T-B |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. |
| Year | 2021 |
| Country | Singapore |
| Company sponsor | National University Hospital, Singapore |
| Other ID(s) | 2020/00865 |
| Cohort 1 | |||||||
|
|||||||